Cargando…
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
Glioblastoma multiforme (GBM), a grade IV astrocytoma, is a lethal brain tumor with a poor prognosis. Despite recent advances in the molecular biology of GBM, neuro-oncologists have very limited treatment options available to improve the survival of GBM patients. A prominent signaling pathway implic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698473/ https://www.ncbi.nlm.nih.gov/pubmed/34944625 http://dx.doi.org/10.3390/biomedicines9121809 |